VVTMF (VVT Med) Total Stockholders Equity: $-2.34 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is VVT Med Total Stockholders Equity?

VVT Med VVTMF Total Stockholders Equity is $-2.34 Mil as of Mar. 2026. The stock has 5 warning signs investors should review.

VVT Med's Total Stockholders Equity for the quarter that ended in Mar. 2026 was $-2.34 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. VVT Med's Book Value per Share for the quarter that ended in Mar. 2026 was $-0.03. The ratio of a company's debt over equity can be used to measure how leveraged this company is. VVT Med's Debt-to-Equity for the quarter that ended in Mar. 2026 was -0.46.

VVT Med  (OTCPK:VVTMF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

VVT Med's Book Value per Share for the quarter that ended in Mar. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-2.336-0)/67.033
=-0.03

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

VVT Med's Debt-to-Equity for the quarter that ended in Mar. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.838 + 0.247) / -2.336
=-0.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VVT Med Total Stockholders Equity Related Terms

VVT Med Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for VVT Med's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VVT Med Total Stockholders Equity Chart

VVT Med Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
-3.54 -5.36 -6.38 -1.82

VVT Med Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -6.76 -4.47 -0.58 -1.82 -2.34
What does a Total Stockholders Equity of $-2.34 Mil mean?
VVT Med (VVTMF) has a Total Stockholders Equity of $-2.34 Mil as of Mar. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for VVT Med and its competitors.
Is VVT Med's Total Stockholders Equity too high?
VVT Med's current Total Stockholders Equity is $-2.34 Mil.
How does VVT Med's Total Stockholders Equity compare to ABT and SYK?
VVT Med's Total Stockholders Equity of $-2.34 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Devices & Instruments company?
A good Total Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for VVT Med and its competitors. VVT Med's current Total Stockholders Equity is $-2.34 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is VVT Med stock overvalued right now?
VVT Med (VVTMF) has a current Total Stockholders Equity of $-2.34 Mil. The current Total Stockholders Equity is $-2.34 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For VVT Med (VVTMF), the current Total Stockholders Equity is $-2.34 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

VVT Med Business Description

Other Exchanges VVTM:Canada
Address 700 West Georgia Street, Suite 2200, Vancouver, BC, CAN, V7Y 1K8
VVT Med Inc is a medical device company, focused on developing and commercializing a range of minimally invasive technologies for treating varicose veins. VVT's research and development activities are based in Israel. The company proudly boasts three products within its portfolio that have achieved commercial production status and are currently available in the market. These products have undergone meticulous design processes, obtaining regulatory approvals across multiple countries.